Transgene SA/ FR0005175080 /
2024-03-28 5:08:01 PM | Chg. +0.028 | Volume | Bid5:40:00 PM | Ask5:40:00 PM | High | Low |
---|---|---|---|---|---|---|
1.140EUR | +2.52% | 56,363 Turnover: 65,664.986 |
1.140Bid Size: 500 | 1.184Ask Size: 700 | 1.174 | 1.128 |
GlobeNewswire
1:00 PM
4DMT Announces Update on Regulatory Interactions and Development Path for 4D-710 for Treatment of Cy...
GlobeNewswire
03-27
Transgene anticipates significant progress from immunotherapy pipeline in 2024 and extends financi...
GlobeNewswire
03-27
Transgene appoints Lucie Larguier as Chief Financial Officer and Christelle Schwoerer as Chief Human...
GlobeNewswire
03-21
CARGO Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business...
GlobeNewswire
03-14
Century Therapeutics Reports Full Year 2023 Financial Results and Provides Business Updates
GlobeNewswire
03-13
Atsena Therapeutics Announces Initiation of Dosing in Second Cohort of Phase I/II Clinical Trial Eva...
GlobeNewswire
03-12
UPDATE -- Fractyl Health Announces New Results From Its Rejuva® Platform Demonstrating Potent and Du...
GlobeNewswire
03-12
Fractyl Health Announces New Results From Its Rejuva® Platform Demonstrating Potent and Durable Effe...
GlobeNewswire
03-06
Transgene to Present New Data on TG4050, an Individualized Cancer Vaccine, at AACR 2024
GlobeNewswire
03-06
Century Therapeutics Announces Six Upcoming Poster Presentations at the 2024 American Association fo...
GlobeNewswire
03-05
Transgene, NEC, and BostonGene Expand Collaboration for Phase I/II Clinical Trial of Neoantigen Canc...
GlobeNewswire
02-29
CARGO Therapeutics to Participate in the 44th Annual Cowen Healthcare Conference
GlobeNewswire
02-12
4DMT Presents Interim Data from 4D-310 INGLAXA Phase 1/2 Clinical Trials for Fabry Disease Cardiomyo...
GlobeNewswire
02-03
4DMT Presents Positive Interim Data from Randomized Phase 2 PRISM Clinical Trial of Intravitreal 4D-...
GlobeNewswire
01-29
4DMT to Host Corporate Webcast to Discuss Interim Data from Phase 2 PRISM Clinical Trial of Intravit...
GlobeNewswire
01-23
4DMT Receives Rare Pediatric Disease Designation from FDA for Aerosolized 4D-710 for Treatment of Cy...
GlobeNewswire
01-22
Transgene Further Strengthens Management Team with Appointment of James Wentworth as Chief Busines...